Seeking Alpha
View as an RSS Feed

Mike Havrilla  

View Mike Havrilla's Articles BY TICKER:
Show Summaries  |  Hide Summaries
  • FDA Calendar Updates: Trinity Biotech Awaiting Two Responses
    Jun. 11, 2009 ACT, TRIB, SKYEF 2 Comments
  • NeuroSearch: Experimental Obesity Drug to Begin Phase 3 Trials
    Jun. 10, 2009 VVUS, ARNA, OREX 1 Comment
  • Five Extreme Biotech Trades
    Jun. 10, 2009 ACAD, ANPI, RPRX Comment!
  • FDA Calendar Updates: Keryx Biopharma Announces Phase 2 Results
    Jun. 9, 2009 MITI, KERX, GSK 1 Comment
  • 7 Extreme FDA Medical Device Trades
    Jun. 8, 2009 NEPH, BVX, NSPH 3 Comments
  • NeoStem: Recent Report Highlights Growth Initiatives
    Jun. 5, 2009 NBS 2 Comments
  • Emisphere: Improving Drug Delivery
    Jun. 5, 2009 EMIS, NVS, PRX 6 Comments
  • FDA Calendar Updates: ABT, AFFY, AZN, LLY, MELA, PFE, SOMX, VPHM
    Jun. 5, 2009 ABT, AFFY, AZN Comment!
  • FDA and Clinical Trial Updates: ADLS, CLDA, GENZ, ISTA, Theratech
    Jun. 3, 2009 THTCF, CLDA, KAMAF 1 Comment
  • 13 Extreme FDA Trades
    Jun. 2, 2009 ABIO, HEB, BDSI 12 Comments
  • FDA, Clinical Trial Calendars: Cancer Drug Updates from ASCO
    Jun. 1, 2009 AZN, RHHBY, OSIP 3 Comments
  • Caraco Pharma Poised for a Turnaround
    May 30, 2009 CPD, MYL, HITK 10 Comments
  • FDA, Clinical Trial Updates: JNJ, INCY, MEDX, CYTX, AGN, PPHM
    May 29, 2009 BAYRY, JNJ, INCY 3 Comments
  • Access Pharma: A Smallcap Cancer Biotech Call Option Trade
    May 28, 2009 ACCP, JNJ, CTIC 13 Comments
  • FDA, Clinical Trial Updates: MAP Pharma, Cytokinetics, Hemispherx Post Big Gains
    May 27, 2009 CYTK, AMGN, MAPP 2 Comments
  • Extreme FDA Trades on Pending Smallcap Medical Device Decisions
    May 26, 2009 NSPH, BVX 1 Comment
  • FDA, Clinical Trial Updates: Genzyme, Human Genome Sciences, Eli Lilly, NeurogesX
    May 22, 2009 LLY, NGSX, SNY Comment!
  • FDA, Clinical Trial Updates: Heart Stents, Cholesterol in the News
    May 21, 2009 JNJ, BSX, ISIS Comment!
  • NIVS IntelliMedia Earnings Review
    May 20, 2009 NIVS Comment!
  • FDA, Clinical Trial Updates: Biogen, Roche, Salix, Cell Therapeutics, Pfizer
    May 20, 2009 BIIB, SLXP, CTIC 3 Comments
  • Pending FDA Decisions: 12 Extreme Trades
    May 20, 2009 HEB, ABIO, DSCO 2 Comments
  • FDA Calendar Updates: Acusphere, AspenBio, Alkermes
    May 19, 2009 SHPG, HLUKY, ALKS 3 Comments
  • NeoStem: Expanding Beyond Stem Cell Banking
    May 18, 2009 NBS Comment!
  • Clinical Trial Updates: Cancer Drugs in Focus as ASCO Approaches
    May 18, 2009 ALTH, CRGN, CTIC 1 Comment
  • Upcoming FDA Decisions and Clinical Trials: Prevacid Goes OTC, Swine Flu Test
    May 15, 2009 XOMA, ALTH, QGEN Comment!
  • Pending Clinical Trial Results: Ten Extreme Trades
    May 14, 2009 GNTAQ, RMTI, PARD 7 Comments
  • FDA, Clinical Trial Updates: Insmed, Jazz Pharma Await Key Results
    May 14, 2009 JAZZ, MRK, INSM Comment!
  • FDA, Clinical Trial Calendar Updates: AMAG Pharma, Immunomedics
    May 13, 2009 AMAG, IMMU Comment!
  • Cell Therapeutics Sells $20M in Common Stock, Warrants
    May 12, 2009 ACCP, CTIC, VNDA Comment!
  • FDA, Clinical Trial Calendar Updates: AstraZeneca Announces Phase III Results
    May 12, 2009 DSCO, MELA, AZN Comment!
  • FDA Calendar Updates: Royal Returns for King Pharma
    May 12, 2009 KG, PTIE, ACUR Comment!
  • Stem Cell Index Surges in Past Week
    May 11, 2009 CYTX, GERN, NBS 3 Comments